Come up with a name for your new list and we'll add to it:
Gala Biotech was acquired by
Cardinal Health on October 14, 2003.
Gala Biotech (Acquired by Cardinal Health - (NYSE: CAH)) developed a portfolio of protein expression technologies in mammalian cells. These systems have applications ranging from early development pro…